Second Affiliated Hospital, School of Medicine, Zhejiang University: Carcinoma trials

The registry lists 17 Carcinoma studies with Second Affiliated Hospital, School of Medicine, Zhejiang University as lead sponsor. 6 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 4Phase 3 1No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study on the Classification of Comprehensive Treatment Effect of Hepatocellular CarcinomaRecruitingNCT06542796Not applicable
• Real-world Analysis on the Efficacy and Safety of Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma （neoHNSCC）RecruitingNCT06011993
• Cadonilimab/Anlotinib in Locally Advanced or Relapsed/Metastatic ESCC Patients After Failure of PD-1 Combined With Platinum-containing ChemotherapyRecruitingNCT05990231Phase 2
• Identification and Prognostic Value of Key Genes in Hepatocellular CarcinomaRecruitingNCT05759858
• Adjuvant Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma After Hepatectomy With Narrow Margin: a Prospective, Multi-center, Randomized Controlled, Open-labelled, Phase III StudyNot yet recruitingNCT05602974Not applicable
• Stereotactic Body Radiation Therapy for the Safety and Prognosis of Small Intrahepatic Recurrent HCCRecruitingNCT05596630Not applicable
• The Synergistic Effect of Portal Venous Supply Control and Immunotherapy in Hepatocellular CarcinomaStatus unknownNCT05760430Phase 2
• Preoperative Stereotactic Body Radiotherapy (SBRT) Followed by Hepatectomy for Centrally Located Hepatocellular Carcinoma: a Prospective, Single-center, Phase I StudyStatus unknownNCT05598060Not applicable
• Stereotactic Body Radiotherapy Based Treatment for Hepatocellular Carcinoma With Extensive Portal Vein Tumor ThrombosisCompletedNCT04966195Not applicable
• Pre-operative Neoadjuvant Therapy Combined With Surgery for Treating Stage III Hepatocellular CarcinomaStatus unknownNCT04961138Not applicable
• Application Value of CEUS Li-RADS in Hepatic Focal Lesions in Patients With Non-high Risk Factors for HCCStatus unknownNCT04920214
• Study of TACE Combined With Lenvatinib to Prevent Postoperative Recurrence in Patients With MVI Positive HCCStatus unknownNCT04911959Phase 1/2
• A Multicenter, Prospective, Phase III Randomized Controlled Clinical Study for the Treatment of N2-3 Nasopharyngeal Carcinoma PatientsStatus unknownNCT04061278Phase 3
• Study of PolyIC and PD-1 mAb in Subjects With Unresectable Hepatocellular CarcinomaStatus unknownNCT03732547Phase 2
• Stereotactic Body Radiotherapy and Microwave Ablation for Recurrent Small Hepatocellular CarcinomaStatus unknownNCT03609268Not applicable
• Stereotactic Body Radiotherapy and Surgery for Early-stage Hepatocellular CarcinomaStatus unknownNCT03609151Not applicable
• The Efficacy of Hepatectomy or TILA-TACE in Patients With Resectable Hepatocellular CarcinomaStatus unknownNCT03314532Not applicable